T-cell masthead image

Publications

Publication

Frontiers in Immunity CoVaccine HT™ Publication

  • External Link
COVID-19: Haun, B.K., Lai, C.Y., Williams, C.A., Wong, T.A.S., Lieberman, M.M., Pessaint, L., Andersen, H., Lehrer, A.T. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. 2020.
Publication

Dr. Christopher J. Schaber’s Interview with The Wall Street Analyzer

In this interview, Dr. Christopher J. Schaber, President and CEO, discusses the Company with The Wall Street Analyzer.
Publication

Article in Drug Target Review

In this article in Drug Target Review, Drs. Donini, Schaber, and Straube discuss innate immunity.
Publication

Dr. Oreola Donini’s Interview with Nature

In this interview, Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses innate immunity and development of Innate Defense Regulator technology with Nature.
Publication

Soligenix Discusses Ricin Toxin Vaccine

Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses the Company's ricin toxin vaccine with ROI-NJ.
Publication

BioWorld Today Ricin Toxin Program Review

In a recent article in BioWorld Today, the Soligenix ricin toxin vaccine program was reviewed, including comments from Dr. Oreola Donini, Chief Scientific Officer of Soligenix.
Publication

Soligenix on IDR technology and SGX942

Dr. Oreola Donini, Chief Scientific Officer of Soligenix, Inc. recently discussed the IDR technology and SGX942 with two publications.
Publication

Journal of Biotechnology – A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy

The publication of data demonstrating the mechanism and broad-spectrum activity of dusquetide in preclinical bacterial infection models